Across the United States, plaque psoriasis affects millions, often requiring patients to juggle multiple treatments for different areas of the body. But what if there was a single, breakthrough solution? This case study dives into how a pioneering biotech company, in partnership with Premier Research, set out to revolutionize plaque psoriasis treatment with an innovative product.
In this case study we go through:
- How we managed two parallel phase 3 clinical trials across multiple sites while maintaining timelines and consistency.
- Strategies for overcoming patient enrollment, compliance, and data integrity challenges, even during the COVID-19 pandemic.
- Innovative remote monitoring and tracking tools and how they helped navigate disruptions during the pandemic.
- Insights into the FDA approval process and the impact of effective collaboration in bringing a new dermatology product to market.
Get the full story
By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Premier Research that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.